2 The Medicine and Healthcare products Regulatory Agency (MHRA) said in a statement said it had approved the vaccine for adult booster doses “after it was found to meet the UK regulator’s standards of safety, quality and effectiveness”.
4 The MHRA’s chief executive June Raine said data from a clinical trial had shown it prompted a “strong immune response” against the original virus and Omicron, and would provide a “sharpened tool in our armoury” as the virus kept evolving.
6 The World Health Organization warned in July that the pandemic was “nowhere near over”, due to the spread of Omicron subvariants and to the lifting of control measures.
7 Half of the Moderna vaccine, called Spikevax bivalent Original/Omicron, targets the original 2020 virus and half the Omicron variant (BA.
9 The MHRA said the vaccine was also found to generate a “good response” against two Omicron subvariants, BA.
10 4 and BA.
12 It also said the vaccine had the same “typically mild” side effects as the original Moderna jab.